Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

AI across the pharmaceutical ecosystem. The Illumina Billion Cell Atlas is the first tranche of its program to build a 5 billion cell atlas over three years, and will be the most comprehensive map of ...

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

The maternal microbiome and immune system have both independent and synergistic effects on fetal brain health - changes in ...

Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

The maternal microbiome and immune system have both independent and synergistic effects on fetal brain health—changes in the ...

Biology has always been an unruly science. Cells divide when they want to. Genes switch on and off like temperamental lights.

AI Impact explores why AI security has outgrown human oversight, plus pricing gains, health care insight and key AI moves in ...

Cancer immunity and immunotherapy research increasingly recognizes that chronic inflammation is a major driver of tumorigenesis, yet the complex and dynamic ...

LAHORE: Artificial intelligence (AI) is enabling researchers to uncover new cancer applications for widely used medicines by ...